Volume 61, Issue 1, Pages (January 2012)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,
Volume 62, Issue 3, Pages (September 2012)
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Volume 55, Issue 1, Pages 1-8 (January 2009)
The PSA Era is not Over for Prostate Cancer
Copyright © 2012 American Medical Association. All rights reserved.
Volume 59, Issue 2, Pages (February 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Volume 47, Issue 4, Pages (April 2005)
Testosterone Therapy in Men With Prostate Cancer
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 61, Issue 6, Pages (June 2012)
Volume 69, Issue 5, Pages (May 2016)
Volume 72, Issue 5, Pages (November 2017)
Volume 60, Issue 5, Pages (November 2011)
Volume 63, Issue 1, Pages (January 2013)
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 4, Pages (October 2013)
Volume 73, Issue 3, Pages (March 2018)
Volume 60, Issue 6, Pages (December 2011)
Let the Games Begin (with EAU Approval)
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Prostate Cancer Epidemic in Sight?
Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer  Olav Erich Yri, Trine Bjoro, Sophie D.
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 4, Pages (October 2015)
The Potential of MicroRNAs as Prostate Cancer Biomarkers
Volume 71, Issue 1, Pages 1-3 (January 2017)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Volume 74, Issue 2, Pages (August 2018)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Shaheen Alanee, Kasmintan Schrader, Kenneth Offit  European Urology 
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Counselling the Prostate Cancer Patient
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 71, Issue 1, Pages (January 2017)
Volume 53, Issue 6, Pages (June 2008)
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Volume 63, Issue 3, Pages (March 2013)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 68, Issue 6, Pages e134-e135 (December 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Volume 62, Issue 6, Pages (December 2012)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Volume 72, Issue 5, Pages (November 2017)
European Urology is “Your” Journal
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Volume 53, Issue 6, Pages (June 2008)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 61, Issue 1, Pages 112-127 (January 2012) Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the Literature  Lars Budäus, Michel Bolla, Alberto Bossi, Cesare Cozzarini, Juanita Crook, Anders Widmark, Thomas Wiegel  European Urology  Volume 61, Issue 1, Pages 112-127 (January 2012) DOI: 10.1016/j.eururo.2011.09.027 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Comparison between three-dimensional conformal radiation therapy (RT) and tomotherapy plan for radiation of the prostate bed. Similar to intensity-modulated radiation therapy, rapid arc, and volumetric-modulated arc therapy, tomotherapy allows conformal spare RT delivery to critical structures, such as the rectum. European Urology 2012 61, 112-127DOI: (10.1016/j.eururo.2011.09.027) Copyright © 2011 European Association of Urology Terms and Conditions